Tectonic Therapeutic Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2016
Net Income	12.16	-105.89	-119.13	-119.71	-72.97	Upgrade
Depreciation & Amortization	2.53	4.17	1.4	1.21	0.85	Upgrade
Share-Based Compensation	6.89	11.52	18.58	15.63	6.8	Upgrade
Other Operating Activities	-84.77	-7.01	1.12	4.07	-2.35	Upgrade
Operating Cash Flow	-63.19	-97.21	-98.03	-98.8	-67.67	Upgrade
Capital Expenditures	1.34	-0.27	-2.46	-1.18	-1.59	Upgrade
Other Investing Activities	83.74	-	-	-	-	Upgrade
Investing Cash Flow	85.08	-0.27	-2.46	-1.18	-1.59	Upgrade
Share Issuance / Repurchase	0.32	0.26	15.47	172.62	129.99	Upgrade
Debt Issued / Paid	-16.35	0	14.9	0	0	Upgrade
Financing Cash Flow	-16.03	0.26	30.37	172.62	129.99	Upgrade
Net Cash Flow	5.86	-97.21	-70.12	72.64	60.74	Upgrade
Free Cash Flow	-61.85	-97.48	-100.49	-99.98	-69.25	Upgrade
Free Cash Flow Per Share	-16.74	-26.74	-28.14	-33.14	-30.29	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).